BREAKING
Home » Archive by Category "Drugs and antibiotics"

U.S. clinical trial for monkeypox antiviral, TPOXX, begins

By

NewsDesk @bactiman63 A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States. Study investigators...

Crimean-Congo hemorrhagic fever: Promising drug candidates identified

By

NewsDesk @bactiman63 Researchers at Karolinska Institutet in Sweden have identified key signalling pathways that when blocked by existing drug candidates limit reproduction of the Crimean-Congo hemorrhagic...

FAU researchers recommend a moratorium on prescribing ivermectin to treat or prevent COVID-19

By

NewsDesk @bactiman63 Ivermectin is a drug approved by the United States Food and Drug Administration (FDA) to treat parasites in animals and in humans with intestinal strongyloidiasis (roundworm) and onchocerciasis (river...

Asthma and COPD treatment: FDA approves generic of Symbicort

By

Today, the U.S. Food and Drug Administration approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of two common pulmonary health conditions:...

Australian TGA approves pediatric tafenoquine for children with Plasmodium vivax malaria

By

NewsDesk @bactiman63 Medicines for Malaria Venture (MMV) today announce that the Australian Therapeutic Goods Administration (TGA) has approved the use of single-dose Kozenis (tafenoquine) in children...

UTI antibiotic, Finafloxacin, as a possible treatment for plague, melioidosis

By

NewsDesk @bactiman63 Working in collaboration with industry, academia and the Defence Threat Reduction Agency (DTRA), an antibiotic developed to treat urinary tract infections, finafloxacin, has been...

New York City announces the availability of Paxlovid COVID-19 oral treatment

By

NewsDesk  @infectiousdiseasenews New York City health officials announced Tuesday the availability of the oral antiviral treatment for symptomatic COVID-19, Paxlovid,  to treat mild-to-moderate COVID-19...

Anti-COVID pills work well against omicron, but antibody drugs are less effective: Lab studies

By

NewsDesk  @infectiousdiseasenews The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in lab tests, according to a new study. However, lab...

Cholangiocarcinoma Foundation congratulates AstraZeneca TOPAZ-1, the first Phase III trial

By

On behalf of patients and families impacted by cholangiocarcinoma (bile duct cancer), the Cholangiocarcinoma Foundation congratulates AstraZeneca and its positive results from the TOPAZ-1 Phase III trial....

Neisseria

New antibiotics to be developed for multidrug resistant gonorrhea: Griffith University receives grant

By

Researchers from the Institute of Glycomics have been awarded more than $1,100,000 million in National Health and Medical Research Council (NHMRC) grant funding to develop new antibiotics for the treatment...